Predictive factors of vascular intima media thickness in HIV-positive subjects

被引:16
作者
Bongiovanni, M. [1 ]
Casana, M. [1 ]
Cicconi, P. [1 ]
Pisacreta, M. [2 ]
Codemo, R. [2 ]
Pelucchi, M. [2 ]
Monforte, A. d'Arminio [1 ]
Bini, T. [1 ]
机构
[1] Univ Milan, San Paolo Hosp, Inst Infect Dis & Trop Med, Dept Med Surg & Dent, I-20142 Milan, Italy
[2] L Sacco Hosp Vialba, Unit Vasc Surg, Milan, Italy
关键词
cardiovascular risk; Doppler; HAART;
D O I
10.1093/jac/dkm414
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The predictive factors of intima media thickness (IMT) in the HIV-infected population are still poorly understood. Patients and methods: We studied three groups of subjects, aged 30-50 years, to find potential predictive factors of carotid and/or femoral thickening (IMT > 1 mm in at least one area): healthy controls (G1, n = 54), HIV-infected naive (G2, n = 53) and highly active antiretroviral treatment (HAART)-treated subjects (G3, n = 133). All the subjects underwent ultrasonography of the carotid and femoral vessels to evaluate IMT. Demographic characteristics of the three groups were comparable, except for gender (G1 had a higher percentage of females) and lipid levels (higher in G3). A total of 115 subjects (47.9%) had carotid and/or femoral IMT: 26 in G1 (48.1%), 21 in G2 (39.6%) and 68 in G3 (51.1%). Independent predictive factors of carotid and/or femoral IMT were older age (OR: 2.81, 95% CI: 1.95-4.04, P < 0.01, for each additional 5 years), triglycerides >= 150 mg/dL (OR: 2.66, 95% CI: 1.27-5.57, P < 0.001), serum glucose >= 110 mg/dL (OR: 5.24, 95% CI: 1.02-27.05, P = 0.04), high homocysteinaemia (OR: 2.75, 95% CI: 1.17-6.46, P = 0.02) and high body mass index (OR: 1.10, 95% CI: 1-1.22, P = 0.05 for each additional unit); females had a lower risk (OR: 0.38, 95% CI: 0.18-0.79, P < 0.01 versus males). HAART use was not associated with IMT (OR: 0.64, 95% CI: 0.27-1.53, P = 0.32 and OR: 0.80, 95% CI: 0.30-2.13, P = 0.20 for G3 and G2 versus G1, respectively). Conclusions: This study demonstrates that traditional risk factors for cardiovascular diseases overshadow the role of HAART in determining premature vascular lesions.
引用
收藏
页码:195 / 199
页数:5
相关论文
共 22 条
[1]   Homocysteinaemia in HIV-infected patients treated with highly active antiretroviral therapy [J].
Bernasconi, E ;
Uhr, M ;
Magenta, L ;
Ranno, A ;
Telenti, A .
AIDS, 2001, 15 (08) :1081-1082
[2]   Pseudoaneurysm of the femoral artery in a HIV-infected man [J].
Bongiovanni, M ;
Pisacreta, M ;
Ortu, M ;
Tordato, E ;
Codemo, R ;
Gervasoni, C ;
Gornati, R ;
Trovati, S ;
Piolini, R ;
Chiesa, E ;
Porretta, T ;
Bini, T .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2004, 28 (04) :451-453
[3]   Predictive factors of hyperhomocysteinemia in HIV-positive patients [J].
Bongiovanni, Marco ;
Casana, Maddalena ;
Pisacreta, Massimo ;
Tordato, Federica ;
Cicconi, Paola ;
Russo, Umberto ;
Ranieri, Roberto ;
Monforte, Antonella d'Arminio ;
Bini, Teresa .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 44 (01) :117-119
[4]   A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].
Carr, A ;
Samaras, K ;
Burton, S ;
Law, M ;
Freund, J ;
Chisholm, DJ ;
Cooper, DA .
AIDS, 1998, 12 (07) :F51-F58
[5]   Carotid intima-media thickness in heavily pretreated HIV-infected patients [J].
Chironi, G ;
Escaut, T ;
Gariepy, J ;
Cogny, A ;
Monsuez, TJ ;
Levenson, J ;
Simon, A ;
Vittecoq, D .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (05) :490-493
[6]   Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure [J].
Currier, JS ;
Kendall, MA ;
Zackin, R ;
Henry, WK ;
Alston-Smith, B ;
Torriani, FJ ;
Schouten, J ;
Mickelberg, K ;
Li, YJ ;
Hodis, HN .
AIDS, 2005, 19 (09) :927-933
[7]   Premature atherosclerosis in HIV-infected individuals - focus on protease inhibitor therapy [J].
Depairon, M ;
Chessex, S ;
Sudre, P ;
Rodondi, N ;
Doser, N ;
Chave, JP ;
Riesen, W ;
Nicod, P ;
Darioli, R ;
Telenti, A ;
Mooser, V .
AIDS, 2001, 15 (03) :329-334
[8]   Combination antiretroviral therapy and the risk of myocardial infarction [J].
Friis-Moller, N ;
Sabin, CA ;
Weber, R ;
Monforte, AD ;
El-Sadr, WM ;
Reiss, P ;
Thiébaut, R ;
Morfeldt, L ;
De Wit, S ;
Pradier, C ;
Calvo, G ;
Law, MG ;
Kirk, O ;
Phillips, AN ;
Lundgren, JD ;
Lundgren, JD ;
Weber, R ;
Monteforte, AD ;
Bartsch, G ;
Reiss, P ;
Dabis, F ;
Morfeldt, L ;
De Wit, S ;
Pradier, C ;
Calvo, G ;
Law, MG ;
Kirk, O ;
Phillips, AN ;
Houyez, F ;
Loeliger, E ;
Tressler, R ;
Weller, I ;
Friis-Moller, N ;
Sabin, CA ;
Sjol, A ;
Lundgren, JD ;
Sawitz, A ;
Rickenbach, M ;
Pezzotti, P ;
Krum, E ;
Meester, R ;
Lavignolle, V ;
Sundström, A ;
Poll, B ;
Fontas, E ;
Torres, F ;
Petoumenos, K ;
Kjær, J ;
Hammer, S ;
Neaton, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21) :1993-2003
[9]   Cardiovascular disease risk factors in HIV patients -: association with antiretroviral therapy.: Results from the DAD study [J].
Friis-Moller, N ;
Weber, R ;
Reiss, P ;
Thiébaut, R ;
Kirk, O ;
Monforte, AD ;
Pradier, C ;
Morfeldt, L ;
Mateu, S ;
Law, M ;
El-Sadr, W ;
De Wit, S ;
Sabin, CA ;
Phillips, AN ;
Lundgren, JD .
AIDS, 2003, 17 (08) :1179-1193
[10]   LIPIDS, LIPOPROTEINS, TRIGLYCERIDE CLEARANCE, AND CYTOKINES IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
GRUNFELD, C ;
PANG, MY ;
DOERRLER, W ;
SHIGENAGA, JK ;
JENSEN, P ;
FEINGOLD, KR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (05) :1045-1052